Latvija -
latviešu -
Pārtikas un veterinārais dienests, Zemkopības ministrija
halo gonseen (2017.) pulveris
dr. nona international ltd. - pulveris
Latvija -
latviešu -
Pārtikas un veterinārais dienests, Zemkopības ministrija
korolen (paziņots) šķidrums
energy group a.s. - šķidrums
Latvija -
latviešu -
Pārtikas un veterinārais dienests, Zemkopības ministrija
herbitassin® pastilas mutes dobumam ar augu ekstraktiem + medus (2019.) pastila
domaco dr.med aufdermaur ag - pastila
Latvija -
latviešu -
Pārtikas un veterinārais dienests, Zemkopības ministrija
herbitassin® iceland moss + honey (2019.) pastila
domaco dr.med aufdermaur ag - pastila
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
zeposia
bristol-myers squibb pharma eeig - ozanimod hidrohlorīds - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imūnsupresanti - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
kesimpta
novartis ireland ltd - ofatumumabs - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
ponvory
janssen-cilag international n.v. - ponesimod - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.